Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Clinical trial NCT00154388 · COMPLETED
Trial details
- NCT number
- NCT00154388
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2007-01-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.